HomeMarkets Markets UBS: Lilly’s Type 2 diabetes and obesity treatment could be ‘one of the best-selling drugs in history’ By news September 22, 2022 0 190 FacebookTwitterPinterestWhatsApp Shares of Eli Lilly & Co. Inc. LLY,+4.89% gained 2.5% in premarket trading on Thursday after UBS upgraded the stock to buy from neutral, saying …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected148,415FansLike396,312FollowersFollow3,750SubscribersSubscribe Latest Articles Markets Friday Thrust – Falling Oil Prices add Fuel to the Rally (for now) Market News This Is How Putin Took Total Control AI The Most Powerful Man in AI Isn’t Worried at All Markets Iran war pushes diesel – the economy’s lifeblood – to record high prices, with no relief on the horizon Energy Houthi offensive in Yemen adds to fear that Iran war could escalate into a wider global conflict Markets Nation’s Second-Largest Homebuilder Warns Immigration Crackdown LeavingTrade Partners With ‘No Crews’ Markets Russia and China Veto U.S. Resolution to Renew U.N. Monitoring of Iran Nuclear Program Market News The US sells more to Brazil than it buys – but Trump is slapping steep tariffs on its exports anyway Markets Trading Community for Serious Investors: Beyond the Retail Noise in 2026 Charts FED Meeting & Portfolio Review (9/15/2026) Markets Post-Fed Thursday: Market Loves Hikes, Microsoft Hates AGI and Trump Meets Xi Markets 2026 Market Outlook and Trading Recommendations: Trading Like The House Market News Warsh defies Trump as Fed hikes rates and signals more to come Market News Economist explains why the Fed rate hike will be ‘catastrophically wrong’ Load more